ImmunityBio
IBRX
IBRX
126 hedge funds and large institutions have $381M invested in ImmunityBio in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6.55% less ownership
Funds ownership: 10.75% → 4.19% (-6.6%)
53% less call options, than puts
Call options by funds: $24M | Put options by funds: $50.7M
Holders
126
Holding in Top 10
–
Calls
$24M
Puts
$50.7M
Top Buyers
| 1 | +$39.5M | |
| 2 | +$12.6M | |
| 3 | +$11M | |
| 4 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$8.24M |
| 5 |
BlackRock
New York
|
+$5.94M |
Top Sellers
| 1 | -$7.89M | |
| 2 | -$2.19M | |
| 3 | -$1.5M | |
| 4 |
Bank of New York Mellon
New York
|
-$1.27M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$951K |